OliX Pharmaceuticals, Inc (KOSDAQ:226950)
105,500
+2,100 (2.03%)
Sep 1, 2026, 3:30 PM KST
70.71% (1Y)
| Market Cap | 2.22T +79.2% |
| Revenue (ttm) | 13.64B +80.9% |
| Net Income | -14.03B |
| EPS | -662.93 |
| Shares Out | 21.06M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 193,029 |
| Open | 101,400 |
| Previous Close | 103,400 |
| Day's Range | 100,000 - 107,100 |
| 52-Week Range | 57,500 - 217,000 |
| Beta | 0.46 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 13, 2026 |